Summary: Researchers tracked long-term socioeconomic data spanning decades. By pairing national medical registries with detailed tax records, the investigators discovered that individuals with early-onset dementia experience significant, progressively worsening work productivity losses up to 15 years before a formal diagnosis is established, with the exact timeline varying drastically based on the specific underlying pathology.
Key Facts
- The $86,000 Invisible Cost: Over the entire pre-diagnostic longitudinal window, individuals who later developed early-onset dementia suffered a staggering total average productivity loss of 74,577 Euros (approximately $86,000 USD) per person compared to their healthy, age-matched peers.
- The Annual Trajectory: The financial deficit represents a massive, accelerating drain, averaging roughly 12,000 Euros (~$13,800 USD) per year per person in lost earning potential as unrecognized symptoms systematically erode workplace performance.
- Pathology-Specific Timelines: The duration of pre-diagnostic productivity loss varied cleanly according to the specific type of neurodegeneration, exposing how differently these diseases attack executive functions:
- Frontotemporal Dementia (FTD): The earliest to manifest financially, showing significant productivity drops 11 years before diagnosis due to early changes in behavior, personality, and executive control.
- Alzheimer’s Disease: Earnings and productivity began to decline steadily 6 years before diagnosis, tracking with early episodic memory drops and structural navigation failures.
- Alpha-Synucleinopathies: Productivity drops were only apparent at the exact time of diagnosis, likely because the sudden onset of obvious motor symptoms (tremors, rigidity) prompts immediate clinical intervention.
- The Diagnostic Delay Catch: Dr. Eino Solje points out that these massive financial deficits are heavily driven by widespread delays in clinical diagnosis. Because early-onset symptoms are rare in young adults, patients spend years struggling with unrecognized cognitive decline before getting accurate specialized screenings.
- Broad Socioeconomic Fallout: The study shows that the hidden onset of young-adult dementia drives an association with a decreased ability to work, sudden spikes in mid-career unemployment, and leaving the workforce years sooner than planned, severely depleting long-term household savings.
- A Call for Cognitive Screening in the Workplace: Because the study relies on retrospective registry data, it shows a clear association rather than direct cause-and-effect. However, Dr. Solje emphasizes that future research must combine neuropsychological testing with workplace monitoring to build early interventions that can support cognitive reserves and delay productivity drops.
Source: AAN
People diagnosed with early-onset dementia had reduced work productivity up to 15 years before diagnosis, according to a study published July 8, 2026, in Neurology, the medical journal of the American Academy of Neurology. Researchers also found the number of years of lower productivity varied depending on the type of dementia.
Early-onset dementia is when someone under 65 is diagnosed with any type of dementia.
The study does not prove that having early-onset dementia lowers productivity in the years prior, it only shows an association.
“Early-onset dementia affects people during their most productive years and is associated with a decreased ability to work, increased unemployment and leaving jobs sooner than planned,” said study author Eino Solje, MD, PhD, of the University of Eastern Finland in Kuopio. “These changes can reduce household income and contribute to broader economic impact. Our study found an association between reduced work productivity and early-onset dementia up to 15 years before diagnosis.”
The study included 793 people diagnosed with early-onset dementia at two Finnish hospitals during a 12-year period. They were matched by age and sex to 7,926 people without dementia. Of those with dementia, 421 had Alzheimer’s disease, 179 had frontotemporal dementia, 46 had alpha-synucleinopathies, which include dementia with Lewy bodies and Parkinson’s disease dementia, and 147 had other forms of dementia including vascular cognitive disorders and mixed dementias.
Researchers used national registries to identify education levels and other health conditions for each participant. They used national tax records to find participants’ incomes.
To determine productivity loss, researchers calculated the average annual income difference between people with early-onset dementia and people without dementia. They also accounted for other factors that could affect the difference, such as education level and other medical conditions.
Researchers found people with early-onset dementia showed progressively increasing productivity losses up to 15 years before diagnosis when compared to people without dementia. Over the course of the study, they had total average productivity losses of 74,577 Euros, or approximately 86,000 U.S. dollars, per person with early-onset dementia.
When looking at different types of dementia, they found average productivity losses for people with Alzheimer’s disease began six years before diagnosis, for people with frontotemporal dementia, 11 years before diagnosis, and for those with alpha-synucleinopathies, losses were only apparent at diagnosis. For other dementias, average productivity losses were consistently high throughout the years.
“Our study found productivity loss was strikingly large, averaging around 12,000 Euros, or approximately 13,800 U.S. dollars, per year per person, with losses beginning up to 15 years before diagnosis,” said Solje. “These findings may partly be explained by delays in diagnosis, which can prolong the period of unrecognized symptoms, and they underscore the harmful, long-term socioeconomic impact of early-onset dementia.”
A limitation of the study was it looked back at data, so it does not show cause and effect.
Solje noted that future research should include neuropsychological tests to track changes in cognition over time, and interventions should be developed that could prevent or delay productivity decline.
Funding: The study was funded by Roche Oy, the Finnish subsidiary of Roche.
Key Questions Answered:
A: It comes down to the specific territories of the brain that these diseases attack first. Alzheimer’s disease primarily starts in the hippocampus, impacting short-term memory, which a high-functioning professional can often compensate for using notes, calendars, and routines for several years. Frontotemporal Dementia, however, directly targets the frontal and temporal lobes, the brain regions that govern social behavior, personality, self-control, and complex decision-making. When these networks degrade, it immediately damages communication, judgment, and workplace relationships, causing productivity to tank up to 11 years before anyone realizes it’s a medical issue.
A: The researchers utilized Finland’s comprehensive national registries, which maintain highly accurate, long-term tracking of every citizen’s health status, education level, and income. By pulling the exact tax records of the 793 early-onset patients and comparing them directly against 7,926 healthy peers of the exact same age, sex, and education tier, the team calculated the precise annual income differences. By adjusting for other co-existing medical conditions, they isolated the unique financial deficit left behind by the unrecognized dementia.
A: The main takeaway is that mid-career productivity drops, sudden uncharacteristic job changes, or performance issues in adults under 65 shouldn’t automatically be blamed on a simple lack of motivation or stress. Dr. Eino Solje emphasizes that we need to develop highly sensitive, non-invasive cognitive screenings that can be deployed the moment an otherwise successful professional begins showing unexpected, prolonged struggles with executive tasks. Catching these changes early can shorten the diagnostic delay, protect families from catastrophic income loss, and allow patients to access supportive treatments years earlier.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by our staff.
About this Alzheimer’s disease research news
Author: Natalie Conrad
Source: AAN
Contact: Natalie Conrad – AAN
Image: The image is credited to Neuroscience News
Original Research: Open access.
“Incidence and Prevalence of Early-Onset Dementia in Finland” by Adolfina Lehtonen, Anna Mäki-Petäjä-Leinonen, Annakaisa Haapasalo, Anne M. Portaankorva, Ave Kivisild, Eino Solje, Helmi Soppela, Iina Rinnankoski, Johanna Krüger, Kalle Aho, Kasper Katisko, Laura Leppänen, Laura Tervonen, Mikko Aaltonen, Noora-Maria Suhonen, Päivi Hartikainen, Sami Heikkinen. Neurology
DOI:10.1212/WNL.0000000000209654
Abstract
Incidence and Prevalence of Early-Onset Dementia in Finland
Objectives
Current epidemiologic data of early-onset dementia (EOD), characterized by the onset of the disease before the age of 65, are notably scarce.
Methods
We evaluated the incidence (from January 2010 to December 2021) and prevalence (on December 31, 2021) of EOD and its subtypes in 2 defined areas in Finland. All visits at the dementia outpatient clinics were manually retrospectively reviewed and reassessed (N = 12,490).
Results
In the population aged ≤65 years, crude incidence of EOD was 12.3/100,000 persons at risk/year based on 794 new cases from January 1, 2010, to December 31, 2021. Incidence rates for EOD were 20.5 and 33.7 per 100,000 person years in the age group of 30–64 and 45–64 years, respectively. The prevalence of EOD was 110.4 in the age group of 30–64 years and 190.3 in the age group 45–64. Alzheimer disease (AD) (48.2%) and behavioral variant frontotemporal dementia (12.7%) were the most frequent subtypes. The incidence of AD increased during the follow-up, whereas incidence of other forms of EOD remained stable.
Discussion
We found higher incidence rates of EOD than previously reported. Unlike other forms of EOD, the incidence of early-onset AD seems to be increasing.
